Smoking and diabetes interplay: A comprehensive review and joint statement
Vincent Durlach1, Bruno Vergès2, Abdallah Al-Salameh3
1Champagne-Ardenne University, UMR CNRS 7369 MEDyC & Cardio-Thoracic Department, Reims University Hospital, Reims, France.
Diabetes & Metabolism
|July 2, 2022
Summary
Smoking significantly elevates diabetes risk and worsens outcomes in individuals with diabetes. This joint position statement offers evidence-based strategies for smoking cessation in all diabetes types.
Area of Science:
- Endocrinology
- Public Health
- Addiction Medicine
Background:
- Smoking is a significant risk factor for developing pre-diabetes and type 2 diabetes.
- In individuals with diagnosed diabetes, smoking exacerbates complications, impairs glycemic control, and increases mortality risk.
Approach:
- This paper is a joint position statement from the French-Speaking Society on Tobacco and the French-Speaking Society of Diabetes.
- It synthesizes current evidence on the smoking-diabetes association and the effects of smoking cessation.
- Focuses on individuals with type 1, type 2, and gestational diabetes mellitus.
Key Points:
- Smoking cessation is crucial for improving health outcomes in diabetic patients.
- Pharmacological and behavioral interventions are effective for smoking cessation in this population.
- Addressing smoking is essential for comprehensive diabetes management.
Conclusions:
- The paper provides a comprehensive overview of the detrimental effects of smoking on diabetes.
- It advocates for integrated smoking cessation support within diabetes care pathways.
- Evidence-based cessation strategies are recommended for all individuals with diabetes who smoke.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
351
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
351
01:22Diabetes Mellitus: Overview and Type I Subtype
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.1K
01:22Diabetes Mellitus: Type 2 and Gestational
2.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.8K
01:20Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
680
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
680
01:19Psychoneuroimmunology: Diabetes and Cancer
61
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
61